Stock JAGX JAGUAR HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Jaguar Health, Inc.

Equities

JAGX

US47010C8055

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-10 pm EDT 		5-day change 1st Jan Change
3.95 USD +9.42% Intraday chart for Jaguar Health, Inc. -5.73% -56.52%
May. 30 Top Premarket Gainers MT
May. 29 Jaguar Health Expands Out-licensing Agreement With Magdalena Biosciences MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jaguar Health : Private Placement Form 8 K
PU
Nasdaq Stocks Soaring to the Top with Strategic Splits: NVDA, INBS, JAGX, SINT, GWAV
AQ
Top Premarket Gainers
MT
Jaguar Health Expands Out-licensing Agreement With Magdalena Biosciences
MT
Investigator-Initiated Trial of Jaguar Health's Crofelemer Yields Positive Results for Functional Diarrhea
AQ
Jaguar Health, Inc. Executes Out- License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia
CI
Jaguar Health, Inc. Announces Results of Third-Party, Investigator-Initiated Study of Crofelemer
CI
Jaguar Health Announces Reverse Stock Split
AQ
Jaguar Health Plans 1-for-60 Reverse Split Next Week
MT
Jaguar Health : Corporate Presentation – May 15, 2024
PU
Earnings Flash (JAGX) JAGUAR HEALTH Reports Q1 Revenue $2.4M, vs. Street Est of $3M
MT
Transcript : Jaguar Health, Inc., Q1 2024 Earnings Call, May 14, 2024
Jaguar Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials and Corporate Updates
AQ
Jaguar Health Applies for Investigational New Animal Drug Status for Potential Dog Diarrhea Treatment
MT
Jaguar Health, Inc. Establishes New Investigational New Animal Drug File with the Center for Veterinary Medicine of the U.S. Food and Drug Administration
CI
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology Conference in Abu Dhabi and Panel Discussion about Microvillus Inclusion Disease
AQ
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society Congress in Support of Company's Expanding Focus on Cancer Supportive Care
AQ
Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care
AQ
Venture Life renews revolving credit facility with Santander and HSBC
AN
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. JAGX Stock
  4. News Jaguar Health, Inc.